We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Artificial Intelligence Could Help Reduce Gadolinium Dose in MRI

By MedImaging International staff writers
Posted on 18 Dec 2018
Image: Example of full-dose, 10 percent low-dose and algorithm-enhanced low-dose (Photo courtesy of RSNA).
Image: Example of full-dose, 10 percent low-dose and algorithm-enhanced low-dose (Photo courtesy of RSNA).
Researchers from Stanford University (Stanford, CA, USA) are using artificial intelligence (AI) to reduce the dose of a contrast agent that may be left behind in the body after MRI exams.

Gadolinium is a heavy metal used in contrast material that enhances MRI images. Recent studies have found that trace amounts of the metal remain in the bodies of people who have undergone exams with certain types of gadolinium. The effects of this deposition are not yet known, although radiologists are working to optimize patient safety while simultaneously preserving the important information provided by gadolinium-enhanced MRI scans. The Stanford researchers have been doing this by studying deep learning, a sophisticated AI technique that teaches computers by examples. By using models called convolutional neural networks, computers can recognize images as well as find subtle distinctions among the imaging data that a human observer might be incapable of discerning.

In order to train the deep learning algorithm, the researchers used MR images from 200 patients who had received contrast-enhanced MRI exams for various indications. They collected three sets of images for each patient: pre-contrast scans, done prior to contrast administration and referred to as the zero-dose scans; low-dose scans, acquired after 10% of the standard gadolinium dose administration; and full-dose scans, acquired after 100% dose administration. The algorithm learned to approximate the full-dose scans from the zero-dose and low-dose images. Neuroradiologists then evaluated the images for contrast enhancement and overall quality.

The results showed that the image quality was not significantly different between the low-dose, algorithm-enhanced MR images and the full-dose, contrast-enhanced MR images. The initial results also demonstrated the potential for creating the equivalent of full-dose, contrast-enhanced MR images without any contrast agent use. These findings suggest the method’s potential for dramatically reducing gadolinium dose without sacrificing diagnostic quality. Future research in the clinical setting will focus on evaluation of the algorithm across a broader range of MRI scanners and with different types of contrast agents.

“Low-dose gadolinium images yield significant untapped clinically useful information that is accessible now by using deep learning and AI,” said study lead author Enhao Gong, Ph.D., researcher at Stanford University. “We’re not trying to replace existing imaging technology. We’re trying to improve it and generate more value from the existing information while looking out for the safety of our patients.”

Related Links:
Stanford University

Ultrasonic Pocket Doppler
SD1
New
Ultrasound Needle Guidance System
SonoSite L25
Portable Color Doppler Ultrasound System
S5000
Portable Color Doppler Ultrasound Scanner
DCU10

Channels

Ultrasound

view channel
Image: The new implantable device for chronic pain management is small and flexible (Photo courtesy of The Zhou Lab at USC)

Wireless Chronic Pain Management Device to Reduce Need for Painkillers and Surgery

Chronic pain affects millions of people globally, often leading to long-term disability and dependence on opioid medications, which carry significant risks of side effects and addiction.... Read more

Nuclear Medicine

view channel
Image: The diagnostic tool could improve diagnosis and treatment decisions for patients with chronic lung infections (Photo courtesy of SNMMI)

Novel Bacteria-Specific PET Imaging Approach Detects Hard-To-Diagnose Lung Infections

Mycobacteroides abscessus is a rapidly growing mycobacteria that primarily affects immunocompromised patients and those with underlying lung diseases, such as cystic fibrosis or chronic obstructive pulmonary... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.